Calling all Nova Scotian healthcare professionals, researchers and academics! CBU, in partnership with Nova Scotia Health Authority, will be hosting the 2024 Health Research Conference at the Membertou Trade & Convention Centre this October. The theme for this year’s conference...
Dr. McIsaac is a dedicated health educator, researcher, and entrepreneur. An Affiliate Scientist with Nova Scotia Health, her research interests are wound and skin care, post-operative surgical care, virtual care, artificial intelligence, and the measurement of outcomes. She has successfully...
Margaret Palmeter has a proven track record of commercializing research and supporting industry-academic partnerships. She comes to Nova Scotia Health in the role of Director of Business Development, Research & Innovation from Dalhousie University, where she was the Founding Director...
Each year as part of Nova Scotia Health’s annual report, the Health Innovation Hub produces a ‘year at a glance’ document that includes highlights of the past year to illustrate the impact that our research, innovation and discovery community are having within the health system, the broader ecosystem, and most...
The Nova Scotia Health Innovation Hub is committed to driving clinical innovation and transformative solutions within the healthcare system. As the single point of entry for partners looking to collaborate with our innovators, researchers, and clinical teams, we streamline access to the expertise and resources needed to bring new ideas...
Dr. Amanda Caissie is focused on digital oncology, patient engagement and artificial intelligence. Through her roles at Nova Scotia Health as an innovator in residence and Medical Director of the Cancer Care Program’s Oncology Transformation Project, she aims to align...
The Institutional Biosafety Committee (IBC) at Nova Scotia Health helps ensure that research and innovation involving biological materials is conducted safely, responsibly, and in accordance with national standards. The IBC reviews projects that use biohazardous agents, human samples, or other regulated biological materials to confirm appropriate safety measures are in...
Fee Criteria The NS Health REB review fees apply to industry sponsored and industry funded studies, meaning that the industry is contractually receiving data/publication rights and/or access to records. The fees apply to the review of the application and not the REB approval. Fee are refunded and invoices cancelled if...
By: Heide Pearson On a shelf in Dr. Mahmoud Elsawy’s office at the QEII Hospital in Halifax, sit six small vials in a cardboard box. Each of those vials once contained 20 million donated chimeric antigen receptor (CAR) T-cells that...
Dr. Kenneth Rockwood is a professor of Geriatric Medicine and Neurology and the Kathryn Allen Weldon Professor of Alzheimer Research at Dalhousie University. He is a Senior Director of the Frailty and Elder Care Network at Nova Scotia Health and...